ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,981Medicare Part D Prescriptions Filled, Including Refills

Rank: 276 out of 3734

$562K Total Retail Price of All Prescriptions

Rank: 562 out of 3734

610 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
45% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 610 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

6% of this provider’s 610 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

0% of this provider’s 11,899 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
CITALOPRAM HBR 490 463 1 16
LEVOTHYROXINE SODIUM 455 418 2 2
FUROSEMIDE 436 394 3 7
JANTOVEN 426 416 4 76
OMEPRAZOLE 395 372 5 4
SIMVASTATIN 304 266 6 1
LISINOPRIL 273 244 7 3
GABAPENTIN 264 244 8 17
HYDROCHLOROTHIAZIDE 245 236 9 9
ATENOLOL 235 232 10 13
SERTRALINE HCL 224 197 11 18
METOPROLOL SUCCINATE 218 218 12 14
AMLODIPINE BESYLATE 199 183 13 5
METOPROLOL TARTRATE 182 173 14 6
TRAMADOL HCL 175 172 15 20
METFORMIN HCL 167 123 16 8
BUMETANIDE 151 151 17 78
TAMSULOSIN HCL 150 137 18 29
GLIPIZIDE 140 138 19 57
CARBIDOPA-LEVODOPA 136 113 20 92
ATORVASTATIN CALCIUM 132 117 21 11
LOSARTAN POTASSIUM 130 130 22 21
HYDROCODONE-ACETAMINOPHEN 127 113 S3 23 12
MIRTAZAPINE 121 121 24 45
ISOSORBIDE MONONITRATE ER 119 118 25 34
CLOPIDOGREL 117 113 26 23
CARVEDILOL 116 105 27 30
PANTOPRAZOLE SODIUM 108 97 28 22
DONEPEZIL HCL 108 108 28 25
POTASSIUM CHLORIDE 106 102 30 19
POLYETHYLENE GLYCOL 3350 105 103 31 53
TRIAMCINOLONE ACETONIDE 105 104 31 131
OXYCODONE HCL 98 97 S2 33 58
SYNTHROID 95 82 34 47
KETOCONAZOLE 91 88 35 204
CRESTOR 89 83 36 28
PLAVIX 88 87 37 39
LIDOCAINE HCL 86 86 38 284
WARFARIN SODIUM 85 85 39 10
LANTUS 84 84 40 54
ENALAPRIL MALEATE 82 75 41 63
SPIRONOLACTONE 81 78 42 80
PRAVASTATIN SODIUM 77 69 43 15
FINASTERIDE 74 69 44 88
NYSTOP 74 70 44 187
DIGOXIN 74 71 44 43
KLOR-CON M20 72 70 47 48
ALLOPURINOL 72 65 47 33
RANITIDINE HCL 71 71 49 32
LEVOXYL 71 71 49 190
ZOLPIDEM TARTRATE 70 52 51 24
OXYCONTIN 70 70 S2 51 121
ALENDRONATE SODIUM 67 67 53 26
CYMBALTA 63 60 54 67
ALBUTEROL SULFATE 63 63 54 128
FENTANYL 63 63 S2 54 65
NOVOLIN R 62 60 57 215
PREDNISONE 61 59 58 42
FAMOTIDINE 61 56 58 60
NAMENDA 56 56 60 44
TRIAMTERENE-HCTZ 56 51 60 73
ADVAIR DISKUS 55 39 62 35
GLIPIZIDE ER 51 39 63 119
DIOVAN 50 40 64 31
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 24, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.